CD8A and neoplasm: Additionally, GM-CSF improves the presentation of peptide antigens to CD4+ and CD8+ T cells, enhances the migration of DCs to lymphoid tissues, and stimulates the secretion of pro-inflammatory cytokines, thereby generating a robust and sustained anti-tumor immune response [199,200].